There are four main types of diabetes: type 1, type 2, gestational diabetes, and a lesser-known category called type 3c. Beyond those, several rare genetic forms exist, bringing the total number of distinct diabetes diagnoses to well over a dozen. They all involve problems with blood sugar regulation, but the causes, severity, and treatment vary enormously from one type to the next.
Type 1 Diabetes
Type 1 diabetes is an autoimmune condition. Your immune system attacks the cells in your pancreas that produce insulin, eventually destroying them almost entirely. Without insulin, glucose builds up in the blood instead of entering your cells for energy. People with type 1 need to take insulin every day, typically a combination of long-acting and rapid-acting forms, for the rest of their lives.
Type 1 is most commonly diagnosed in children and teenagers, though it can appear at any age. Current diagnostic guidelines now include antibody testing to confirm the autoimmune process, which helps distinguish type 1 from type 2 in adults who might otherwise be misdiagnosed. It accounts for roughly 5 to 10 percent of all diabetes cases.
Type 2 Diabetes
Type 2 is by far the most common form, making up about 90 to 95 percent of diabetes diagnoses. It develops when your body either stops making enough insulin or your cells stop responding to it properly, a problem called insulin resistance. Unlike type 1, it isn’t autoimmune. Risk factors include excess weight, physical inactivity, family history, and age.
Type 2 is often managed initially with lifestyle changes and oral medications. Some people with type 2 will eventually need insulin as well, particularly if the condition progresses and the pancreas produces less insulin over time. A diabetes diagnosis is confirmed when your A1C (a measure of average blood sugar over two to three months) reaches 6.5 percent or higher.
Five Clusters Within Type 2
Researchers have proposed that type 2 diabetes isn’t really one disease. A landmark study from Scandinavia identified five distinct clusters of adult-onset diabetes based on clinical measurements, and the findings have been replicated in other populations. Each cluster carries different risks and may eventually require different treatment strategies:
- Severe autoimmune diabetes (SAID): Represents about 6% of adult cases. These individuals test positive for autoimmune antibodies, similar to type 1, and have low insulin production, relatively low body weight, and poor blood sugar control. This group overlaps with what’s sometimes called latent autoimmune diabetes in adults (LADA).
- Severe insulin-deficient diabetes (SIDD): About 18% of cases. Similar profile to the autoimmune cluster but without the antibodies. This group had the highest rates of eye damage (retinopathy), with 23% showing signs even soon after diagnosis, along with higher rates of nerve damage.
- Severe insulin-resistant diabetes (SIRD): About 15% of cases. Characterized by extreme insulin resistance and high body weight. This cluster carries the greatest risk for kidney disease and nonalcoholic fatty liver disease.
- Mild obesity-related diabetes (MOD): About 22% of cases. High body weight but without the severe insulin resistance seen in SIRD.
- Mild age-related diabetes (MARD): The largest group at 39%. These individuals develop diabetes later in life with no extreme characteristics, and their outcomes tend to be the most favorable.
These clusters haven’t yet changed how doctors officially classify diabetes, but they highlight why two people with a “type 2” diagnosis can have very different experiences and complications.
Gestational Diabetes
Gestational diabetes develops during pregnancy in people who didn’t have diabetes before. Hormonal changes during pregnancy can make your cells more resistant to insulin, and if your pancreas can’t compensate by producing more, blood sugar rises. It’s typically diagnosed during the second or third trimester through routine screening.
Gestational diabetes usually resolves after delivery, but it significantly raises the risk of developing type 2 diabetes later in life. It also increases the chance of complications during pregnancy, including high birth weight and preterm delivery, which is why blood sugar monitoring during pregnancy matters.
Type 3c (Pancreatogenic) Diabetes
Type 3c diabetes develops when the pancreas is physically damaged by another condition, reducing its ability to make insulin. The damage isn’t autoimmune (as in type 1) and isn’t driven by insulin resistance (as in type 2). Instead, it results from conditions like chronic pancreatitis, pancreatic cancer, cystic fibrosis, hemochromatosis (iron overload), or surgical removal of part of the pancreas.
Chronic pancreatitis is the most common cause. Long-term inflammation scars the pancreatic tissue, eventually preventing it from producing both insulin and the digestive enzymes it normally makes. That’s a key difference from other types: people with type 3c often have digestive problems alongside their blood sugar issues, because the same organ damage affects both functions.
Type 3c is frequently misdiagnosed as type 2, which matters because the treatment approach can differ. Insulin needs in type 3c can be unpredictable, and patients may also need enzyme supplements to digest food properly.
MODY: Genetic Diabetes in Young People
Maturity-onset diabetes of the young (MODY) is a group of genetic forms caused by single-gene mutations. Unlike type 1 or type 2, MODY follows a clear inheritance pattern: if one parent carries the mutation, each child has a 50% chance of inheriting it. MODY accounts for an estimated 1 to 5 percent of all diabetes cases, though many people with it are misdiagnosed with type 1 or type 2.
There are multiple subtypes, but three account for the vast majority of cases:
- GCK-MODY (MODY2): The mildest form, responsible for 30 to 50 percent of MODY cases. People with this type have slightly elevated fasting blood sugar but often have no symptoms at all, and diabetes-related complications are extremely rare. Most don’t need treatment.
- HNF1A-MODY (MODY3): The most common form, accounting for 50 to 70 percent of cases. It causes progressively rising blood sugar with typical diabetes symptoms like frequent urination, excessive thirst, and fatigue. Over time, uncontrolled blood sugar can damage the blood vessels in the eyes and kidneys. People with this subtype also have a higher-than-average risk of developing benign liver tumors.
- HNF4A-MODY (MODY1): Makes up 5 to 10 percent of cases and progresses similarly to MODY3. One distinctive feature is that babies born with this mutation tend to weigh more than average and may have abnormally low blood sugar at birth, even though other signs of diabetes don’t appear until childhood or young adulthood.
A fourth subtype, HNF1B-MODY (sometimes called MODY5), accounts for another 5 to 10 percent and is unique because it combines diabetes with kidney abnormalities, particularly fluid-filled cysts, along with possible pancreatic issues and gout.
Getting the correct MODY diagnosis through genetic testing matters because treatment differs sharply by subtype. Some forms respond well to a specific class of oral medication, while GCK-MODY typically requires no treatment at all.
Neonatal Diabetes
Neonatal diabetes appears within the first six months of life, which distinguishes it from type 1 (type 1 almost never appears that early). It’s caused by genetic mutations that directly affect how the pancreas produces or releases insulin. There are two forms: transient neonatal diabetes, which resolves in infancy but can return later in life, and permanent neonatal diabetes, which requires lifelong treatment.
The genetic picture is becoming clearer. About 25 percent of permanent neonatal diabetes cases are caused by mutations in a gene called KCNJ11, another 10 to 15 percent by mutations in the ABCC8 gene, and roughly 20 to 25 percent by mutations in the insulin gene itself. Identifying the specific mutation matters because some forms respond to oral medications rather than insulin injections, which is a significant quality-of-life difference for families.
How the Types Compare
The practical differences between diabetes types come down to three things: what’s going wrong, how it’s treated, and how quickly it needs attention.
In type 1 and permanent neonatal diabetes, insulin production is severely impaired or absent, so insulin replacement is non-negotiable from the start. In type 2, the body still produces insulin (at least initially), so treatment often begins with lifestyle changes and oral medications. Type 3c falls somewhere in between: insulin production can vary depending on how much pancreatic damage has occurred. Gestational diabetes is typically managed with dietary changes and blood sugar monitoring, though some cases require insulin. And MODY treatment is entirely subtype-dependent, ranging from nothing at all to oral medications to insulin.
Recognizing which type you’re dealing with is more than an academic exercise. Misdiagnosis is common, particularly between type 1 and type 2 in adults, between type 2 and type 3c, and between type 1 or type 2 and MODY. Each misdiagnosis can lead to treatment that’s less effective or entirely unnecessary. If your diabetes doesn’t fit the expected pattern, such as a type 2 diagnosis at a young age with normal weight, or poor response to standard medications, genetic testing or further evaluation can point toward a more accurate diagnosis.